Member Company Reports
Companies are listed in alphabetical order
1 April – 30 September 2011
- Abbott Australasia
977k - Actelion 22k
- Alcon Pharmaceuticals 21k
- Allergan 52k
- AMGEN Australia 197k
- AstraZeneca 933k
- Baxter Healthcare 41k
- Bayer Australia 326k
- Biogen Idec Australia 168k
- Boehringer Ingelheim 567k
- Bristol-Myers Squibb Australia 128k
- Celgene Pty Ltd 34k
- CSL Limited 387k
- Eli Lilly Australia 667k
- FIT BioCeuticals
237k - Fresenius Kabi
63k - Genzyme Australasia Pty Ltd 44k
- Gilead Sciences 52k
- GlaxoSmithKline Australia 720k
- iNova Pharmaceuticals 58k
- Ipsen 60k
- Janssen 684k
- LEO Pharma 222k
- Lundbeck 64k
- Merck Serono 76k
- Merck Sharp & Dohme Australia 591k
- Mundipharma 237k
- Norgine 57k
- Novartis Pharmaceuticals 1305k
- Novo Nordisk 212k
- Nycomed 181k
- Pfizer Australia 4452k
- Roche Products 1228k
- sanofi-aventis 176k
- Servier Laboratories 797k
- Shire Australia 78k
- UCB Pharma 126k
Previous Educational Event Reports
Page updated: December 2011